Overview

Dietary Supplements for COVID-19

Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
This is a double blind, placebo controlled, phase III randomized controlled trial evaluating the effects of the dietary supplements vitamin C, vitamin D, vitamin K, and zinc versus placebo on the overall health, symptom severity, and symptom duration of outpatients diagnosed with SARS-CoV-2.
Phase:
Phase 3
Details
Lead Sponsor:
The Canadian College of Naturopathic Medicine
Collaborators:
New Roots Herbal
Ottawa Hospital Research Institute
Vitazan Professional
Treatments:
Cholecalciferol
Vitamin D
Vitamin K
Vitamin K 2
Vitamins